Mangalam Organics share price & results
- Jun 2026
- Sept 2026
Pine-chemistry manufacturer of camphor, terpene derivatives and synthetic resins from turpentine, sold B2B to paints, adhesives and tyre makers, and B2C via the Mangalam and CamPure consumer brands.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 163 | +43.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.8 | −0.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 5.3 | −23.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 7.66 | +4.0 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | -9.70 | +4.9 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 17.28 | +14.2 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −9.4% 1Y
1Y: ₹515.5 on 24 Oct 2025 → ₹466.8. High ₹618.65 (5 May 2026), low ₹367.05 (30 Mar 2026).
- Previous close
- ₹468.9
- Market cap
- ₹407 Cr
- 52-week range
- ₹367.05 – ₹618.65
- One year
- −8.16%
- Price to earnings (TTM to Jun 2026)
- 17.33×
- Return on equity (TTM to Jun 2026)
- 7.66%
Overview
- Symbol
- NSE:MANORG
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Mangalam Organics Limited does
Based on the company's own presentations, annual report and earnings calls.
Mangalam Organics manufactures terpene chemistry products (camphor, dipentene, sodium acetate, isobornyl acetate, isoborneol) and synthetic resins (terpene phenolic resin, alkyl phenolic resin, rosin esters) from turpentine sourced globally, at its single plant in Khopoli, Raigad district, Maharashtra. Its B2B Terpene and Synthetic Resin operations supply industrial customers in paints, adhesives, tyres/rubber, printing ink, textiles, leather and fragrance & flavor. Through its subsidiary Mangalam Brands Private Limited, it also sells camphor tablets and homecare/personal-care products directly to consumers under the Mangalam and CamPure brands, distributed via general trade, modern trade, e-commerce and exports.
Segments
- B2B - Terpene Operations
- B2B - Synthetic Resin Operations
- B2C - Retail Operations
- Manufacturing plant
- 1 (Khopoli, Raigad district, Maharashtra)
- Camphor capacity
- ~10,000 MT/year (expansion completed 2022)
- Bhimseni/Isoborneol Flakes capacity
- 2,500 MT/year (expansion completed 2025)
- Product portfolio
- 100+
- Domestic sales/marketing offices
- 8 offices across India
- Modern Trade retail presence
- 4,700+ organized retail stores
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: −23% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 101 | 104 | 114 | 130 | 122 | 135 | 163 |
| Expenses | 100 | 87 | 89 | 101 | 135 | 110 | 103 | 145 |
| Operating profit | 10 | 14 | 15 | 13 | -5 | 12 | 31 | 18 |
| Operating margin | 9.2% | 13.5% | 14.0% | 11.5% | −3.5% | 10.1% | 23.2% | 10.8% |
| Other income | 1 | 0 | 0 | 6 | 18 | 1 | -12 | 0 |
| Interest | 4 | 5 | 7 | 6 | 6 | 7 | 7 | 6 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 7 | 5 |
| Profit before tax | 2 | 4 | 3 | 8 | 3 | 2 | 5 | 6 |
| Tax rate | 30.3% | 25.3% | 29.3% | 16.0% | 24.7% | 26.0% | 30.6% | 16.5% |
| Net profit | 1 | 3 | 2 | 7 | 2 | 1 | 4 | 5 |
| EPS (₹ per share) | 1.61 | 3.30 | 2.53 | 8.08 | 2.23 | 1.30 | 4.40 | 6.21 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 492 | 405 | 410 | 501 |
| Expenses | 495 | 371 | 362 | 449 |
| Operating profit | -3 | 34 | 48 | 52 |
| Other income | 1 | 2 | 2 | 13 |
| Interest | 15 | 15 | 20 | 26 |
| Depreciation | 18 | 19 | 19 | 22 |
| Profit before tax | -34 | 3 | 11 | 18 |
| Net profit | -27 | 4 | 8 | 14 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 296 | 270 | 274 | 281 | 300 | 295 |
| Borrowings | 196 | 176 | 163 | 263 | 352 | 288 |
| Other liabilities | 43 | 34 | 24 | 40 | 69 | 50 |
| Total liabilities | 543 | 489 | 470 | 593 | 729 | 640 |
| Fixed assets | 181 | 205 | 214 | 227 | 262 | 245 |
| Capital work in progress | 8 | 0 | 0 | 0 | 61 | 0 |
| Investments | 0 | 1 | 1 | 1 | 0 | 1 |
| Other assets | 354 | 284 | 255 | 365 | 406 | 395 |
| Total assets | 543 | 489 | 470 | 593 | 729 | 640 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 26 | -85 | 66 | 55 | -46 | 31 |
| Cash from investing | -28 | -83 | -32 | -27 | -30 | -31 |
| Cash from financing | 2 | 166 | -33 | -28 | 75 | 1 |
| Net cash flow | 0 | -1 | 1 | 0 | -1 | 0 |
| Free cash flow | -2 | -167 | 33 | 26 | -78 | -5 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 37 | 33 | 45 | 67 | 49 | 53 |
| Inventory days | 314 | 319 | 174 | 152 | 288 | 304 |
| Days payable | 71 | 41 | 29 | 22 | 47 | 43 |
| Cash conversion cycle | 280 | 311 | 190 | 197 | 290 | 314 |
| Working capital days | 110 | 108 | 57 | 48 | 19 | 54 |
| Return on capital employed | 50.0% | 20.0% | −4.0% | 4.0% | 6.0% | 7.0% |
| Dividend payout | 2.0% | 2.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Ownership
Who owns it
Promoters hold 58.64% as of Sept 2026; institutions cut 2.09 pts since Jun 2026.
- Promoters 58.64%
- Foreign institutions 0.12%
- Domestic institutions 0.00%
- Public 41.23%
Who is on the register
Named in the Sep 2026 filing
Every holder of Mangalam Organics Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 21.36% | unchanged | |
| 9.96% | unchanged | |
| 9.43% | unchanged | |
| 6.76% | unchanged | |
| 6.67% | unchanged | |
| 5.57% | unchanged | |
| 2.17% | unchanged | |
| 2.01% | unchanged | |
| 2.01% | unchanged | |
| 1.53% | unchanged | |
| AIF | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Mangalam Organics Limited
Free account: one company. Everything above stays public.
Write why you follow Mangalam Organics Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
Learn to analyse Mangalam Organics Limited
Guides on how to read this kind of business and the numbers that matter.







